{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T08:05:11Z","timestamp":1776413111864,"version":"3.51.2"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,15]]},"DOI":"10.7759\/cureus.101653","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T07:49:22Z","timestamp":1768549762000},"source":"Crossref","is-referenced-by-count":1,"title":["Perioperative Glucagon-Like Peptide-1 Receptor Agonist Therapy and Postoperative Outcomes in Adult Foot and Ankle Surgery: A Scoping Review"],"prefix":"10.7759","author":[{"given":"Mohamed","family":"Zahed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alzahraa Faris","family":"Alesawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Elkohail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Ghazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Fell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Hashem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.68390","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonists: exploring their impact on diabetes, obesity, and cardiovascular health through a comprehensive literature review","volume":"16","author":"Hamed K","year":"2024","unstructured":"Hamed K, Alosaimi MN, Ali BA, et al.. Glucagon-like peptide-1 (GLP-1) receptor agonists: exploring their impact on diabetes, obesity, and cardiovascular health through a comprehensive literature review. Cureus. 2024, 16:e68390. 10.7759\/cureus.68390","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15829","article-title":"Opportunities to optimize lifestyle interventions in combination with glucagon-like peptide-1-based therapy","volume":"26","author":"Dash S","year":"2024","unstructured":"Dash S. Opportunities to optimize lifestyle interventions in combination with glucagon-like peptide-1-based therapy. Diabetes Obes Metab. 2024, 26:3-15. 10.1111\/dom.15829","journal-title":"Diabetes Obes Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.3c01049","article-title":"Discovery of a novel glucagon-like peptide-1 (GLP-1) analogue from bullfrog and investigation of its potential for designing GLP-1-based multiagonists","volume":"67","author":"Jiang N","year":"2024","unstructured":"Jiang N, Su D, Chen D, et al.. Discovery of a novel glucagon-like peptide-1 (GLP-1) analogue from bullfrog and investigation of its potential for designing GLP-1-based multiagonists. J Med Chem. 2024, 67:180-198. 10.1021\/acs.jmedchem.3c01049","journal-title":"J Med Chem"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-025-05664-9","article-title":"Effects of semaglutide in patients with chronic ankle instability: evidence from a prospective cohort","volume":"20","author":"Zhang J","year":"2025","unstructured":"Zhang J, Wang C, Wang J, et al.. Effects of semaglutide in patients with chronic ankle instability: evidence from a prospective cohort. J Orthop Surg Res. 2025, 20:243. 10.1186\/s13018-025-05664-9","journal-title":"J Orthop Surg Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30013-X","article-title":"Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial","volume":"5","author":"Sorli C","year":"2017","unstructured":"Sorli C, Harashima SI, Tsoukas GM, et al.. Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial. Lancet Diabetes Endocrinol. 2017, 5:251-260. 10.1016\/S2213-8587(17)30013-X","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding JP","year":"2021","unstructured":"Wilding JP, Batterham RL, Calanna S, et al.. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021, 384:989-1002. 10.1056\/NEJMoa2032183","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jot.2022.02.001","article-title":"Targeting the GLP-1\/GLP-1R axis to treat osteoarthritis: a new opportunity?","volume":"32","author":"Meurot C","year":"2022","unstructured":"Meurot C, Jacques C, Martin C, et al.. Targeting the GLP-1\/GLP-1R axis to treat osteoarthritis: a new opportunity?. J Orthop Translat. 2022, 32:121-129. 10.1016\/j.jot.2022.02.001","journal-title":"J Orthop Translat"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12178-025-09978-3","article-title":"The effects of GLP-1 agonists on musculoskeletal health and orthopedic care","volume":"18","author":"Gatto A","year":"2025","unstructured":"Gatto A, Liu K, Milan N, Wong S. The effects of GLP-1 agonists on musculoskeletal health and orthopedic care. Curr Rev Musculoskelet Med. 2025, 18:469-480. 10.1007\/s12178-025-09978-3","journal-title":"Curr Rev Musculoskelet Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102782","article-title":"GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review","volume":"75","author":"Alfaris N","year":"2024","unstructured":"Alfaris N, Waldrop S, Johnson V, Boaventura B, Kendrick K, Stanford FC. GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review. EClinicalMedicine. 2024, 75:102782. 10.1016\/j.eclinm.2024.102782","journal-title":"EClinicalMedicine"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1262-3636(08)73397-4","article-title":"Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes","volume":"34","author":"Gautier JF","year":"2008","unstructured":"Gautier JF, Choukem SP, Girard J. Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes. Diabetes Metab. 2008, 34:65-72. 10.1016\/S1262-3636(08)73397-4","journal-title":"Diabetes Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00098","article-title":"The impact of glucagon-like peptide-1 on bone metabolism and its possible mechanisms","volume":"8","author":"Zhao C","year":"2017","unstructured":"Zhao C, Liang J, Yang Y, Yu M, Qu X. The impact of glucagon-like peptide-1 on bone metabolism and its possible mechanisms. Front Endocrinol (Lausanne). 2017, 8:98. 10.3389\/fendo.2017.00098","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2024.05.079","article-title":"Decreased risk of readmission and complications with preoperative GLP-1 analog use in patients undergoing primary total joint arthroplasty","volume":"39","author":"Buddhiraju A","year":"2024","unstructured":"Buddhiraju A, Kagabo W, Khanuja HS, Oni JK, Nikkel LE, Hegde V. Decreased risk of readmission and complications with preoperative GLP-1 analog use in patients undergoing primary total joint arthroplasty. J Arthroplasty. 2024, 39:2911-2915.e1. 10.1016\/j.arth.2024.05.079","journal-title":"J Arthroplasty"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/00003086-200110000-00016","article-title":"Complications of foot and ankle surgery in patients with diabetes","volume":"391","author":"Marks RM","year":"2001","unstructured":"Marks RM. Complications of foot and ankle surgery in patients with diabetes. Clin Orthop Relat Res. 2001, 391:153-161. 10.1097\/00003086-200110000-00016","journal-title":"Clin Orthop Relat Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.L.01302","article-title":"Neuropathy and poorly controlled diabetes increase the rate of surgical site infection after foot and ankle surgery","volume":"96","author":"Wukich DK","year":"2014","unstructured":"Wukich DK, Crim BE, Frykberg RG, Rosario BL. Neuropathy and poorly controlled diabetes increase the rate of surgical site infection after foot and ankle surgery. J Bone Joint Surg Am. 2014, 96:832-839. 10.2106\/JBJS.L.01302","journal-title":"J Bone Joint Surg Am"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaf088","article-title":"Glucagon-like peptide-1 receptor agonists and peri-procedural aspiration risk","volume":"9","author":"Ho CN","year":"2025","unstructured":"Ho CN, Ayers AT, Kohn MA, Umpierrez GE, Klonoff DC. Glucagon-like peptide-1 receptor agonists and peri-procedural aspiration risk. J Endocr Soc. 2025, 9:bvaf088. 10.1210\/jendso\/bvaf088","journal-title":"J Endocr Soc"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.24.01287","article-title":"GLP-1 receptor agonists in orthopaedic surgery: implications for perioperative care and outcomes: an orthopaedic surgeon's perspective","volume":"107","author":"Ramanathan R","year":"2025","unstructured":"Ramanathan R, Lee JY, Dalton JF, et al.. GLP-1 receptor agonists in orthopaedic surgery: implications for perioperative care and outcomes: an orthopaedic surgeon's perspective. J Bone Joint Surg Am. 2025, 107:1879-1886. 10.2106\/JBJS.24.01287","journal-title":"J Bone Joint Surg Am"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.5003","article-title":"Preoperative GLP-1 receptor agonist use and risk of postoperative respiratory complications","volume":"331","author":"Dixit AA","year":"2024","unstructured":"Dixit AA, Bateman BT, Hawn MT, Odden MC, Sun EC. Preoperative GLP-1 receptor agonist use and risk of postoperative respiratory complications. JAMA. 2024, 331:1672-1673. 10.1001\/jama.2024.5003","journal-title":"JAMA"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103408","article-title":"Evaluation of safety of preoperative GLP-1 receptor agonists in patients undergoing elective surgery: a systematic review, meta-analysis and meta-regression","volume":"87","author":"Kamarajah SK","year":"2025","unstructured":"Kamarajah SK, Gudiozzi N, Findlay JM, Lee MJ, Pinkney T, Markar SR. Evaluation of safety of preoperative GLP-1 receptor agonists in patients undergoing elective surgery: a systematic review, meta-analysis and meta-regression. EClinicalMedicine. 2025, 87:103408. 10.1016\/j.eclinm.2025.103408","journal-title":"EClinicalMedicine"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.46658\/JBIMES-24-09","article-title":"Scoping reviews","author":"Peters MDJ","year":"2024","unstructured":"Peters MDJ, Godfrey C, McInerney P, Munn Z, Tricco AC, Khalil H. Scoping reviews. In: JBI Manual for Evidence Synthesis. Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z (ed): JBI, 2024. 10.46658\/JBIMES-24-09"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.11124\/JBIES-22-00123","article-title":"Recommendations for the extraction, analysis, and presentation of results in scoping reviews","volume":"21","author":"Pollock D","year":"2023","unstructured":"Pollock D, Peters MD, Khalil H, et al.. Recommendations for the extraction, analysis, and presentation of results in scoping reviews. JBI Evid Synth. 2023, 21:520-532. 10.11124\/JBIES-22-00123","journal-title":"JBI Evid Synth"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco AC","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, et al.. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018, 169:467-473. 10.7326\/M18-0850","journal-title":"Ann Intern Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1177\/10711007251328370","article-title":"GLP-1 agonists' effect on infection and union after tibiotalar fusion, subtalar fusion, triple arthrodesis","volume":"46","author":"Levidy MF","year":"2025","unstructured":"Levidy MF, Vatsia S, Tucker S, Rowe N, Macdonald A, Aynardi M. GLP-1 agonists' effect on infection and union after tibiotalar fusion, subtalar fusion, triple arthrodesis. Foot Ankle Int. 2025, 46:617-621. 10.1177\/10711007251328370","journal-title":"Foot Ankle Int"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1053\/j.jfas.2025.05.002","article-title":"Impact of glucagon-like peptide-1 receptor agonists on postoperative outcomes following ankle fracture open reduction and internal fixation","volume":"64","author":"Morningstar J","year":"2025","unstructured":"Morningstar J, Lauck BJ, Bank N, Lalli T. Impact of glucagon-like peptide-1 receptor agonists on postoperative outcomes following ankle fracture open reduction and internal fixation. J Foot Ankle Surg. 2025, 64:644-648. 10.1053\/j.jfas.2025.05.002","journal-title":"J Foot Ankle Surg"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2025.09.054","article-title":"The impact of glucagon-like peptide-1 receptor agonist use on clinical outcomes after total hip and knee arthroplasty: a systematic review and meta-analysis of 346,899 patients [Article in Press]","author":"Lee S","year":"2025","unstructured":"Lee S, Singh K, Clark SC, Goh GS. The impact of glucagon-like peptide-1 receptor agonist use on clinical outcomes after total hip and knee arthroplasty: a systematic review and meta-analysis of 346,899 patients [Article in Press]. J Arthroplasty. 2025, 10.1016\/j.arth.2025.09.054","journal-title":"J Arthroplasty"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.artd.2024.101506","article-title":"Glucagon-like peptide-1 receptor agonist use is not associated with increased complications after total knee arthroplasty in patients with type-2 diabetes","volume":"30","author":"Heo KY","year":"2024","unstructured":"Heo KY, Goel RK, Fuqua A, et al.. Glucagon-like peptide-1 receptor agonist use is not associated with increased complications after total knee arthroplasty in patients with type-2 diabetes. Arthroplast Today. 2024, 30:101506. 10.1016\/j.artd.2024.101506","journal-title":"Arthroplast Today"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng Z","year":"2024","unstructured":"Zheng Z, Zong Y, Ma Y, Tian Y, Pang Y, Zhang C, Gao J. Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024, 9:234. 10.1038\/s41392-024-01931-z","journal-title":"Signal Transduct Target Ther"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-24633-0","article-title":"GLP-1RA in JBMMSCs promoted osteogenic differentiation via modulating CREB and BRD4 signaling mediated proliferation and stemness","volume":"15","author":"Liu H","year":"2025","unstructured":"Liu H, Tian Y, Bao X, Li Y. GLP-1RA in JBMMSCs promoted osteogenic differentiation via modulating CREB and BRD4 signaling mediated proliferation and stemness. Sci Rep. 2025, 15:40773. 10.1038\/s41598-025-24633-0","journal-title":"Sci Rep"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.G.01673","article-title":"The management of ankle fractures in patients with diabetes","volume":"90","author":"Wukich DK","year":"2008","unstructured":"Wukich DK, Kline AJ. The management of ankle fractures in patients with diabetes. J Bone Joint Surg Am. 2008, 90:1570-1578. 10.2106\/JBJS.G.01673","journal-title":"J Bone Joint Surg Am"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2025.112746","article-title":"Perioperative glucagon-like Peptide-1 receptor agonist use and clinical outcomes following lower extremity fracture fixation: a large retrospective cohort study with two year follow up","volume":"56","author":"Pereira DE","year":"2025","unstructured":"Pereira DE, Tummala S, Mittal MM, Obey M, Berkes MB, McAndrew CM, Wilson JL. Perioperative glucagon-like Peptide-1 receptor agonist use and clinical outcomes following lower extremity fracture fixation: a large retrospective cohort study with two year follow up. Injury. 2025, 56:112746. 10.1016\/j.injury.2025.112746","journal-title":"Injury"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2025.04.001","article-title":"Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement","volume":"135","author":"Oprea AD","year":"2025","unstructured":"Oprea AD, Ostapenko LJ, Sweitzer B, et al.. Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement. Br J Anaesth. 2025, 135:48-78. 10.1016\/j.bja.2025.04.001","journal-title":"Br J Anaesth"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/444490-perioperative-glucagon-like-peptide-1-receptor-agonist-therapy-and-postoperative-outcomes-in-adult-foot-and-ankle-surgery-a-scoping-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T07:49:23Z","timestamp":1768549763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/444490-perioperative-glucagon-like-peptide-1-receptor-agonist-therapy-and-postoperative-outcomes-in-adult-foot-and-ankle-surgery-a-scoping-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.101653","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,15]]}}}